Fractyl Health (GUTS) Current Leases (2023 - 2026)
Fractyl Health's (GUTS) quarterly Current Leases came in at $5.1 million in Q1 2026, up 2.98% YoY from $5.0 million in Q1 2025, and up 0.72% on a QoQ basis from $5.1 million in Q4 2025.
Fractyl Health (GUTS) Current Leases (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Current Leases data on file, last reported at $5.1 million in Q1 2026.
- Quarterly Current Leases rose 2.98% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 2.98% YoY) and the FY2025 annual result came in at $5.1 million, up 2.99% from the prior year.
- Current Leases grew to $5.1 million in Q1 2026, from $5.1 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $5.1 million in Q1 2026 to a low of $2.7 million in Q4 2023.
- A 4-year average of $4.6 million and a median of $5.0 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases jumped 81.47% — and 2026, when it increased 2.98%.
- Tracing GUTS's Current Leases over 4 years: stood at $2.7 million in 2023, then jumped by 81.47% to $5.0 million in 2024, then climbed by 2.99% to $5.1 million in 2025, then rose by 0.72% to $5.1 million in 2026.
- The last three Current Leases figures came in at $5.1 million (Q1 2026), $5.1 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | - |
| 10 | Fractyl Health | 122.64 Mn | 122.64 Mn | - | 5.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.18 Mn |
| Mar 31, 2026 | 5.14 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Sep 30, 2025 | 5.07 Mn |
| Jun 30, 2025 | 5.03 Mn |
| Mar 31, 2025 | 4.99 Mn |
| Dec 31, 2024 | 4.96 Mn |
| Sep 30, 2024 | 4.92 Mn |
| Jun 30, 2024 | 4.88 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 2.73 Mn |